Galanin and vasoactive intestinal peptide messenger RNAs increase following axotomy of adult sympathetic neurons.
The adult rat superior cervical ganglion (SCG) contains low levels of galanin- and vasoactive intestinal peptide-(VIP) like immunoreactivity, with very few immunostained principal neurons. Immunoreactivity for both neuropeptides increases in these neurons after explantation or postganglionic axotomy in vivo. Northern blot analysis has demonstrated concomitant increases in mRNAs encoding these peptides. To localize cells in axotomized ganglia which increase their expression of these mRNAs, we performed in situ hybridization studies. In control SCG, only a few principal neurons contained mRNA for either galanin or VIP. After 48 h in organ culture, galanin mRNA was expressed in the majority of principal neurons. At 48 h after in vivo axotomy of both postganglionic trunks of the SCG, the internal and external carotid nerves, the distribution and number of neurons, expressing galanin mRNA increased similarly to that seen in culture. Lesioning either trunk alone produced increases in galanin mRNA localized to those regions of the ganglion containing neurons that project into the lesioned trunk. Transection of the predominantly preganglionic cervical sympathetic trunk increased galanin mRNA expression in a small population of neurons near that nerve trunk. The distributions of these labeled neurons, together with previous neuroanatomical studies, suggests that they had been axotomized by the lesions. Similar studies examining VIP mRNA expression demonstrated that although considerably fewer VIP mRNA expressing neurons than galanin mRNA expressing neurons were present after axotomy, the distribution of neuropeptide mRNA-positive cells were similar in both cases. These observations suggest that increases in the peptides galanin and VIP after nerve transection result from changes in the levels of their mRNAs in those neurons that have been axotomized.
Mohney
R P
RP
Department of Neurosciences, Case Western Reserve University, School of Medicine, Cleveland, Ohio 44106.
Siegel
R E
RE
Zigmond
R E
RE
D000818:Animals; D001369:Axons / Q000502:physiology*; D019004:Galanin; D017403:In Situ Hybridization; D008297:Male; D009474:Neurons / Q000502:physiology*; D009479:Neuropeptides / Q000096:biosynthesis*; D015345:Oligonucleotide Probes; D009924:Organ Culture Techniques; D010452:Peptide Biosynthesis; D012333:RNA, Messenger / Q000096:biosynthesis*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017783:Superior Cervical Ganglion / Q000166:cytology / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000166:cytology / Q000502:physiology*; D014660:Vasoactive Intestinal Peptide / Q000096:biosynthesis*
D009479:Neuropeptides; D015345:Oligonucleotide Probes; D012333:RNA, Messenger; D014660:Vasoactive Intestinal Peptide; D019004:Galanin